Atypical preeclampsia with systemic lupus erythematosus and elevated soluble fms-like tyrosine kinase 1/placental growth factor ratio.
Kazuya MimuraTakuji TomimatsuMasayuki EndoTadashi KimuraPublished in: The journal of obstetrics and gynaecology research (2021)
While systemic lupus erythematosus is often complicated by preeclampsia, it is difficult to differentiate between its exacerbation and preeclampsia. The soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio is unknown in systemic lupus erythematosus with preeclampsia before 20 weeks of gestation. Three nulliparous women with systemic lupus erythematosus developed preeclampsia at 13, 13, and 17 weeks of gestation with sFlt-1/PlGF ratios of 427, 865, and 525, respectively. Two patients terminated their pregnancies and delivered within 2 weeks, while one experienced intrauterine fetal death 4 weeks after the measurements. Their symptoms gradually improved, and all patients were discharged within 3 months. The sFlt-1/PlGF ratio may be used in the differential diagnosis of preeclampsia and systemic lupus erythematosus exacerbation before 20 weeks of gestation.
Keyphrases
- tyrosine kinase
- systemic lupus erythematosus
- growth factor
- gestational age
- early onset
- epidermal growth factor receptor
- end stage renal disease
- disease activity
- pregnancy outcomes
- ejection fraction
- preterm infants
- newly diagnosed
- chronic obstructive pulmonary disease
- chronic kidney disease
- preterm birth
- prognostic factors
- patient reported outcomes